Effects of gut microbiota and probiotics on Alzheimer’s disease
Abstract: Alzheimer’s disease (AD) is a progressive neurodegenerative disease with high morbidity, disability, and fatality rate, significantly increasing the global burden of public health. The failure in drug discovery over the past decades has stressed the urgency and importance of seeking new perspectives. Recently, gut microbiome (GM), with the ability to communicate with the brain bidirectionally through the microbiome–gut–brain axis, has attracted much attention in AD-related studies, owing to their strong associations with amyloids, systematic and focal inflammation, impairment of vascular homeostasis and gut barrier, mitochondrial dysfunction, etc., making the regulation of GM, specifically supplementation of probiotics a promising candidate for AD treatment. This article aims to review the leading-edge knowledge concerning potential roles of GM in AD pathogenesis and of probiotics in its treatment and prevention.
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Effects of gut microbiota and probiotics on Alzheimer’s disease ; volume:12 ; number:1 ; year:2021 ; pages:573-580 ; extent:8
Translational Neuroscience ; 12, Heft 1 (2021), 573-580 (gesamt 8)
- Creator
-
Guo, Libing
Xu, Jiaxin
Du, Yunhua
Wu, Weibo
Nie, Wenjing
Zhang, Dongliang
Luo, Yuling
Lu, Huixian
Lei, Ming
Xiao, Songhua
Liu, Jun
- DOI
-
10.1515/tnsci-2020-0203
- URN
-
urn:nbn:de:101:1-2022082914561483510051
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:31 AM CEST
Data provider
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Guo, Libing
- Xu, Jiaxin
- Du, Yunhua
- Wu, Weibo
- Nie, Wenjing
- Zhang, Dongliang
- Luo, Yuling
- Lu, Huixian
- Lei, Ming
- Xiao, Songhua
- Liu, Jun